Showing results (1-10 of 463) with videos related to
Sort By:
Pageof 47
Journal of Gastroenterology and Hepatology|August 19, 2008
HIV and hepatitis C coinfectionGail V Matthews, Gregory J DoreNature Reviews. Gastroenterology & Hepatology|March 23, 2011
Treatment of acute HCV infectionJason Grebely, Gail V Matthews, Gregory J DoreCurrent Opinion in HIV and AIDS|September 8, 2011
Future of hepatitis C therapy: development of direct-acting antiviralsGregory J Dore, Gail V Matthews, Jürgen RockstrohAntiviral Therapy|May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovirGail V Matthews, David A Cooper, Gregory J DoreInfectious Disease Clinics of North America|May 21, 2018
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject DrugsMarianne Martinello, Gregory J Dore, Gail V Matthews, et al.AIDS Reviews|May 20, 2016
Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-AnalysisMarianne Martinello, Janaki Amin, Gail V Matthews, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.Nature Reviews. Gastroenterology & Hepatology|May 19, 2018
Management of acute HCV infection in the era of direct-acting antiviral therapyMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.Hepatology Communications|March 30, 2023
Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021Joanne Carson, Sebastiano Barbieri, Gail V Matthews, et al.Pageof 47